Healthcare Services

Oncology Ablation Market Insights Highlighting Opportunities and Drivers Supporting Growth to 2030

April 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Oncology Ablation Market By 2030 Starting From Its 2026 Size?

The oncology ablation market has seen rapid expansion in recent years. Its value is projected to increase from $1.45 billion in 2025 to $1.64 billion in 2026, reflecting a compound annual growth rate (CAGR) of 12.5%. This historical growth can be ascribed to the increasing occurrence of liver, kidney, and lung cancers, a rising demand for minimally invasive treatments, the enhanced availability of advanced imaging technologies, the establishment of more hospitals and specialty oncology centers, and growing awareness of ablation as an alternative to surgery.

The oncology ablation market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach $2.61 billion, expanding at a compound annual growth rate (CAGR) of 12.4%. This projected growth is driven by several factors, including the rise of targeted and personalized ablation treatments, the increased acceptance of percutaneous and laparoscopic ablation methods, continuous technological progress in ablation devices, the expansion of oncology facilities in developing areas, and the growing incorporation of digital systems for patient management and monitoring. Key trends expected during this period involve the increasing use of digital platforms for managing oncology ablation procedures, the greater integration of AI and machine learning in tumor diagnosis and treatment planning, the expanding application of precision medicine and genomic profiling in ablation therapy, enhanced automation within ablation devices and surgical instruments, and the growing deployment of IoT-enabled monitoring for ablation devices and patient results.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18415&type=smp

What Primary Drivers Are Shaping The Development Of The Oncology Ablation Market?

The rising number of cancer diagnoses is anticipated to propel the growth of the oncology ablation market going forward. Cancer diagnosis involves identifying and confirming the presence of cancer through medical tests, imaging, and pathological analysis of tissue samples. This increase in cancer diagnoses is attributed to several factors, including aging populations, enhanced screening programs, heightened awareness leading to earlier detection, and environmental factors. Oncology ablation is utilized to treat tumors identified via cancer diagnoses, offering minimally invasive options to destroy tumors and improve patient outcomes. For example, in May 2024, the National Cancer Institute, the US-based federal government’s principal agency for cancer research and training, projected approximately 2,001,140 new cancer cases in the United States in 2024, with prostate, lung, and colorectal cancers collectively making up around 48% of all diagnoses in men. By 2040, the annual number of new cancer cases is expected to surge to 29.9 million, indicating a significant future increase in cancer incidence. Furthermore, in June 2022, the American Cancer Society, a US-based non-profit cancer awareness organization, reported that about 1.9 million new cancer cases were diagnosed in the USA in 2022. Therefore, the increasing number of cancer diagnoses will drive the oncology ablation market.

Which Segment Categories Define The Oncology Ablation Market?

The oncology ablation market covered in this report is segmented –

1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation

2) By Treatment: Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation

3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer

Subsegments:

1) By Radiofrequency Ablation: Monopolar Radiofrequency Ablation, Bipolar Radiofrequency Ablation

2) By Microwave Ablation: Single-Probe Microwave Ablation, Multi-Probe Microwave Ablation

3) By Cryoablation: Cryo-Needle Ablation, Cryo-Generator System Ablation

4) By Irreversible Electroporation Ablation: Transurethral IRE, Transperineal IRE, Percutaneous IRE

What Key Trends Are Influencing The Development Of The Oncology Ablation Market?

Leading companies in the oncology ablation market are developing innovative products, such as advanced ablation systems with enhanced precision, integrated imaging technologies for real-time guidance, and improved safety features. These advanced ablation systems, known for their improved precision, are medical devices that leverage sophisticated technology to accurately target and destroy abnormal tissue, like tumors, while minimizing damage to healthy surrounding tissue. For example, in March 2024, Medtronic Plc, an Ireland-based medical equipment manufacturing company, obtained US Food and Drug Administration approval for the OsteoCool 2.0 bone tumor ablation system, which is designed to treat painful bone metastases and benign tumors such as osteoid osteoma. This updated system includes significant enhancements, notably the capability to use four internally cooled probes simultaneously, which facilitates the ablation of two vertebral bodies at once or the creation of larger ablation zones in non-spinal applications.

Who Are The Top Companies Competing In The Oncology Ablation Market?

Major companies operating in the oncology ablation market are Medtronic plc, Boston Scientific Corporation, AngioDynamics Inc, EDAP TMS S.A., Merit Medical Systems Inc, Misonix Inc, BSD Medical Corporation, Sonacare Medical, Chongqing Haifu Medical Technology Co Ltd, HealthTronics Inc, Galil Medical Inc, SonaCare Medical LLC, BVM Medical Ltd, BTG International Ltd, Mermaid Medical, HistoSonics Inc, Medigus Ltd, Miramar Labs Inc, KLS Martin Group, Endocare Inc, InnovaCore Inc, IceCure Medical Inc, RF Medical Co Ltd, CSA Medical Inc

Read the full oncology ablation market report here:

https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report

How Does The Oncology Ablation Market Perform Across Major Global Regions?

North America was the largest region in the oncology ablation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology ablation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Oncology Ablation Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=18415&type=smp

Browse Through More Reports Similar to the Global Oncology Ablation Market 2026, By The Business Research Company

Therapeutic Dental Equipment Global Market Report

https://www.thebusinessresearchcompany.com/report/therapeutic-dental-equipment-global-market-report

Dental Equipment And Supplies Global Market Report

https://www.thebusinessresearchcompany.com/report/dental-equipment-and-supplies-global-market-report

Dental Hygiene Instrument Global Market Report

https://www.thebusinessresearchcompany.com/report/dental-hygiene-instrument-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795